DNA distribution in non-small-cell lung carcinomas and its relationship to clinical behavior.

No abstract is available for this paper.

• Publication year

  1985

• Venue

  Cytometry

• Publication date

  1985-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/CYTO.990060412PMID 2990835
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Influence of cellular DNA content on survival in advanced ovarian cancer.

  1984cited by this paper
• Prognostic significance of nuclear DNA content in mammary adenocarcinomas in humans.

  1984cited by this paper
• Prediction of early course of breast carcinoma by thymidine labeling

  1983cited by this paper
• Non-small-cell lung carcinoma: tumor characterization on the basis of flow cytometrically determined cellular heterogeneity.

  1983cited by this paper
• Diagnostic and biological implications of flow cytometric DNA content analysis in lung cancer.

  1983cited by this paper
• Isopycnic density-gradient centrifugation: a separation parameter which improves flow cytometric measurements on heterogeneous tumors.

  1983cited by this paper
• Flow cytometry in clinical cancer research.

  1983cited by this paper
• Flow cytometric analysis of DNA content of bone marrow cells in patients with plasma cell myeloma: clinical implications.

  1982cited by this paper
• Ploidy and proliferative characteristics in monoclonal gammopathies.

  1982cited by this paper
• Flow cytometry of lung carcinoma: a comparison of DNA stemline and cell cycle distribution with histology.

  1982cited by this paper
• Prognostic implications of ploidy and proliferative activity in human solid tumors.

  1982cited by this paper
• Flow cytofluorometric DNA analyses of metastases of human malignant melanomas.

  1982cited by this paper
• DNA profile and tumour progression in patients with superfical bladder tumours

  1982cited by this paper
• DNA distribution in human colon carcinomas and its relationship to clinical behavior.

  1982cited by this paper
• Histological Typing of Lung Tumours 1

  1981cited by this paper
• Nuclear DNA measurements in squamous cell carcinoma of the lung: a guide for prognostic evaluation.

  1981cited by this paper
• Labeling index as a prognostic marker in non-Hodgkin's lymphomas.

  1981cited by this paper
• Clinical application of flow cytometry: a review.

  1981cited by this paper
• Kinetic parameters and the course of the disease in breast cancer

  1981cited by this paper
• Clonal heterogeneity of small-cell anaplastic carcinoma of the lung demonstrated by flow-cytometric DNA analysis.

  1980cited by this paper
• Pretreatment tumor mass, cell kinetics, and prognosis in multiple myeloma.

  1980cited by this paper
• Flow microfluorometric deoxyribonucleic acid (DNA) analysis supplementing routine histopathologic diagnosis of biopsy specimens.

  1980cited by this paper
• Percentage of cells in the S phase of the cell cycle in human lymphoma determined by flow cytometry.

  1980cited by this paper
• Advanced stage and early relapse of breast carcinomas associated with high thymidine labeling indices.

  1979cited by this paper
• Pretherapeutic detection of tumour resistance and the results of tumour chemotherapy.

  1979cited by this paper
• In vitro determination of thymidine-3H labeling index in human solid tumors.

  1974cited by this paper
• HISTOLOGICAL TYPING OF LUNG TUMOURS

  1968cited by this paper
• Nonparametric Estimation from Incomplete Observations

  1958cited by this paper

• Flow Cytometry of Solid Tumours

  2021cites this paper
• The Relative Biological Effectiveness of Carbon Ion Radiation Therapy for Early Stage Lung Cancer.

  2020cites this paper
• Predicting In Vitro Cancer Cell Survival Based on Measurable Cell Characteristics

  2019cites this paper
• Live Cell Imaging Supports a Key Role for Histone Deacetylase as a Molecular Target during Glioblastoma Malignancy Downgrade through Tumor Competence Modulation

  2019cites this paper
• Quantification of Multiple Tumor Clones Using Gene Array and Sequencing Data.

  2017influential citation
• Modeling the Cellular Response of Lung Cancer to Radiation Therapy for a Broad Range of Fractionation Schedules

  2017cites this paper
• Flow Cytometric Measurement of Aneuploid DNA Content Correlates with High S-Phase Fraction and Poor Prognosis in Patients with Non-Small-Cell Lung Cancer

  2013cites this paper
• State-based simulations of tumor response to radiotherapy

  2012influential citation
• Three-Dimensional Nuclear Luminance Analysis in Well-Differentiated Adenocarcinoma of the Lung

  2011cites this paper
• The flow-cytometric DNA content of the plasma cells of patients with multiple myeloma is a prognostic factor: a single institution experience

  2010cites this paper
• CD133 is indicative for a resistance phenotype but does not represent a prognostic marker for survival of non‐small cell lung cancer patients

  2009cites this paper
• Establishment and characterization of a human large cell lung cancer cell line with neuroendocrine differentiation

  2009cites this paper
• Drug Resistance in Lung Cancer

  2007cites this paper
• DNA analysis, chemoresistance testing and hormone receptor levels as prognostic factors in advanced ovarian carcinoma

  2006cites this paper
• Dehydroepiandrosterone inhibits the proliferation of human umbilical vein endothelial cells by enhancing the expression of p53 and p21, restricting the phosphorylation of retinoblastoma protein, and is androgen‐ and estrogen‐receptor independent

  2005cites this paper
• The relevance of flow-cytometric DNA content in the evaluation of lung cancer

  2005cites this paper
• Predicting chemosensitivity of tumors

  2005cites this paper
• A case of multiple leiomyomatous lesions of the lung: An analysis of flowcytometry and hormone receptors

  2004cites this paper
• Cellular drug resistance in lung cancer

  2004cites this paper
• Characteristics of long-term survivors of untreated lung cancer.

  2002cites this paper
• Flow cytometric analysis of DNA content and proliferation and immunohistochemical staining of Ki-67 in non-small cell lung cancer.

  2001cites this paper
• Cell proliferation markers in human solid tumors: assessing their impact in clinical oncology.

  2001cites this paper
• Ceramide mimics tumour necrosis factor‐α in the induction of cell cycle arrest in endothelial cells

  2000cites this paper
• Prognostic value of cytokinetic parameters in lung cancer after in vivo bromodeoxyuridine labelling.

  1999cites this paper
• DNA flow cytometry in surgically treated lung cancer--prognostic significance.

  1999cites this paper
• Cloning of a human cancer cell line (NSCLC-N6) and comparative study of the clones in vitro.

  1998cites this paper
• Multivariate analyses of DNA index, p62c-myc, and clinicopathological status of patients with ovarian cancer.

  1998cites this paper
• Chromosomal duplication accompanies allelic loss in non-small cell lung carcinoma.

  1998cites this paper
• [Prognostic value of flow cytometry in squamous cell bronchogenic cancer. A retrospective study of 61 cases].

  1997cites this paper
• Flow cytometric analysis of tumor DNA profile related to response to treatment and survival in small-cell lung cancer

  1997cites this paper
• Interference with c-myc expression and RB phosphorylation during TNF-mediated growth arrest in human endothelial cells.

  1997cites this paper
• Resistance mechanisms and their regulation in lung cancer.

  1996cites this paper
• DNA ploidy and protein content in bronchioloalveolar carcinoma multi-variable flow cytometry.

  1996cites this paper
• Non-small cell lung cancer. Morphology and DNA flow cytometry.

  1996cites this paper
• High cell proliferation activity determined by DNA flow cytometry and prognosis in epidermoid lung carcinoma.

  1995cites this paper
• Resistance mechanisms in human lung cancer.

  1995cites this paper
• Nuclear DNA and nuclear protein content of tumor cell in adenocarcinoma of the lung.

  1995cites this paper
• Flow cytometric analysis of the dna content of adenocarcinoma of the lung, especially for patients with stage 1 disease with long term follow‐up

  1995cites this paper
• Genetic factors in the aetiology of malignant mesothelioma.

  1995cites this paper
• The prognostic value of cell proliferation in non-small cell lung cancer assessed with tritiated thymidine and anti-PCNA antibodies.

  1994cites this paper
• [Contribution of flow cytometry in the prognostic evaluation of non-small-cell lung cancers. Review of the literature].

  1994cites this paper
• Cell kinetics: prognostic and therapeutic implications in human tumours

  1994cites this paper
• Advances in flow cytometry for diagnostic pathology.

  1994cites this paper
• Critical analysis of the methods commonly employed in the assessment of cell proliferation: advantages of the NOR silver-staining technique in routine cyto-histopathology.

  1993cites this paper
• Flow Cytometric DNA Analysis in Small Lesions of Non-small Cell Lung Cancer.

  1993cites this paper
• Prognostic value of oncoproteins for the survival of patients with nonsmall cell lung carcinomas.

  1993cites this paper
• Prognostic significance of flow cytometry in non-small-cell lung cancer.

  1993cites this paper
• Preoperative Prediction of Gastric Cancer Extension by in Vitro Labelling Index of Bromodeoxyuridine

  1993cites this paper
• Cytokinetic analysis of lung cancer by in vivo bromodeoxyuridine labelling.

  1993cites this paper
• PET imaging of non-small-cell lung carcinoma with carbon-11-methionine: relationship between radioactivity uptake and flow-cytometric parameters.

  1993cites this paper
• Fine needle aspiration for flow cytometric DNA analysis of lung cancer

  1992cites this paper
• Nuclear DNA Content and Expression of ras Oncogene p21 in Non-Small Cell Lung Cancer.

  1992cites this paper
• Accuracy of the bronchoscopic DNA content analysis of non‐small‐cell lung carcinoma

  1992cites this paper
• The flow cytometric nuclear-DNA content, tumor-origin, nuclear size and prognosis in squamous-cell lung-cancer.

  1992cites this paper
• Tumour growth rates in squamous carcinoma of the head and neck measured by in vivo bromodeoxyuridine incorporation and flow cytometry.

  1992cites this paper
• Metastasizing Mixed Tumor of Salivary Glands: A Clinicopathologic and Flow Cytometric Analysis

  1992cites this paper
• DNA content in correlation with postsurgical stage in non-small cell lung cancer.

  1992cites this paper
• Prognostic value of nuclear DNA content and expression of the ras oncogene product in lung cancer.

  1991cites this paper
• Interphase nucleolar organiser regions and survival in squamous cell carcinoma of the bronchus: a 10 year follow up study of 138 cases.

  1991cites this paper
• Dna ploidy and cell‐cycle analysis: Tools for assessment of cancer prognosis

  1991cites this paper
• Establishment and characterization of a new Ewing's sarcoma cell line.

  1991cites this paper
• DNA aneuploidy and low S-phase fraction as favourable prognostic signs in metastatic melanoma.

  1991cites this paper
• Comparison of image analysis and flow cytometric determination of cellular DNA content.

  1991cites this paper
• Lung Carcinoma in 1,336 Patients

  1991cites this paper
• Flow cytometric dna content analysis in neuroendocrine carcinoma of the lung. Correlation with survival and histologic subtype

  1991cites this paper
• [Flow cytometric analysis of DNA content in paraffin-embedded tissue in head and neck cancer (the second report)--primary lesions of laryngeal cancer].

  1991cites this paper
• [Flow cytometric analysis of DNA content in paraffin-embedded tissue in head and neck cancer--evaluation of malignant potential and carcinogenic process of nasoparanasal tumor].

  1991cites this paper
• Diploid predominance and prognostic significance of S-phase cells in malignant mesothelioma.

  1991cites this paper
• Ploidy and Proliferation Evaluated by Flow Cytometry. An Overview of Techniques and Impact in Oncology

  1991cites this paper
• Prognostic applications of DNA analysis in solid malignant lesions in humans.

  1991cites this paper
• Could cell kinetics be a predictor of prognosis in non-small cell lung cancer?

  1991cites this paper
• FLOW CYTOMETRIC ANALYSIS OF NUCLEAR DNA CONTENT AND RADIATION RESPONSE IN ESOPHAGEAL CANCER

  1991cites this paper
• In vitro-Verfahren zur Bestimmung der Prognose und individuellen Therapie von Patienten mit nichtkleinzelligen Bronchialkarzinomen

  1991cites this paper
• Thymidine labelling index as prognostic factor in resected non-small cell lung cancer.

  1990cites this paper
• Prognostic and therapeutic significance of the flow cytometric nuclear DNA content in non‐small cell lung cancer

  1990cites this paper
• Flow cytometry in the quantitation of DNA aneuploidy and cell proliferation in human disease.

  1990cites this paper
• Flow cytometric analysis of tumour DNA profile related to response to radiotherapy and survival in inoperable lung cancer.

  1990cites this paper
• Prognostic value of S‐phase fraction and DNA ploidy studied with in vivo administration of bromodeoxyuridine on human gastric cancers

  1990cites this paper
• Differences of nuclear DNA content between central and peripheral squamous cell carcinoma of the lung.

  1990cites this paper
• Relationship of DNA ploidy to chemoresistance of tumors as measured by in vitro tests.

  1990cites this paper
• Prognostic significance of tumor ploidy in patients with advanced ovarian carcinoma

  1990cites this paper
• Flow cytometric analysis of the DNA content of non‐small cell lung cancer ploidy as a significant prognostic indicator in squamous cell carcinoma of the lung

  1990cites this paper
• Cell proliferation kinetics in human solid tumors: relation to probability of metastatic dissemination and long-term survival.

  1989cites this paper
• Flow-cytometric prognostic factors for the survival of patients with ovarian carcinoma: a 5-year follow-up study.

  1989cites this paper
• Flow cytometric analysis DNA content in esophageal carcinoma. Correlation with histologic and clinical features

  1989cites this paper
• Nuclear DNA content by cytofluorometry of stage I adenocarcinoma of the lung in relation to postoperative recurrence.

  1989cites this paper
• Flow cytometric analysis of DNA content in human ovarian cancers.

  1989cites this paper
• Cytogenetic abnormalities in lung cancer.

  1989cites this paper
• DNA cytofluorometric and nuclear morphometric analyses of lung adenocarcinoma

  1989cites this paper
• DNA-content, inflammatory tissue response and tumour size in human lung carcinoma.

  1989cites this paper
• Flow cytometric analysis of malignant pleural mesotheliomas.

  1989cites this paper
• The labelling index: a prognostic factor in head and neck carcinoma.

  1989cites this paper
• Establishment of cell lines from serial samples from two patients with lung tumours before and after chemotherapy

  1989cites this paper
• Flow cytometric measurements of DNA and other cell components in human tumors: a critical appraisal.

  1989cites this paper
• DNA flow cytometric studies of 66 human lung tumors analyzed before treatment. Prognostic implications.

  1989cites this paper
• Comparison of S-phase fractions measured by flow cytometry and autoradiography in human transplant tumors.

  1988cites this paper
• Comparative analysis of [3H]‐thymidine labelling index and monoclonal antibody Ki‐67 in non‐Hodgkin's lymphomas

  1988cites this paper
• Five-year follow-up study of independent clinical and flow cytometric prognostic factors for the survival of patients with non-small cell lung carcinoma.

  1988cites this paper
• Flow cytometric analysis of DNA and cell proliferation in ovarian tumors

  1988cites this paper
• The complex clinical model of metastasis.

  1988cites this paper